Research and experimental development on natural sciences and engineering
ARXX THERAPEUTICS AS
Revenue 2024
NOK 5.0m
Operating profit
NOK −66.8m
Equity
NOK 13.5m
Incorporated
2015
Share capital
NOK 5.5m
Organisation
Established
2015-03-25
Industry code
72.100
Legal form
AS
Group structure
Eier · 100.0%
CALLUNA PHARMA AS
Company
ARXX THERAPEUTICS AS
No subsidiaries
Industry and activity
- NACE
- 72.100 — Research and experimental development on natural sciences and engineering
- Sector
- Private non-financial incorporated enterprises
- Activity
- Legemiddelutvikling.
Business address
Gaustadalléen 21, 0349 OSLO
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.